Clinical Trial Update: Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male

View source ↗

Summary

This trial compares the safety and pharmacokinetics of Hanmi's HCP1004 with Vimovo (naproxen/esomeprazole) in healthy Korean male volunteers, assessing PK and t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• HCP1004
• VIMOVO (naproxen/esomeprazole)

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Rheumatoid Arthritis | Status: COMPLETED